Nomination Committee for AGM 2020

In preparation for the annual general meeting 2020, the company’s three largest shareholders, or groups of shareholders, have appointed members of the nomination committee. As the three largest shareholders or groups of shareholders in October 2019 appointed their representatives, the nomination committee consists of the following members:

  • Bo Rydlinger, chairman of the nomination committee, background from banking and investments, appointed by a group of shareholders representing about 21 percent of shares and votes;
  • Daniel Johnsson, entrepreneur, business developer and investor, appointed by a group of shareholders representing about 24 percent of shares and votes;
  • Clas Sonesson, Chief Scientific Officer (CSO) at IRLAB and one of IRLAB’s founders. Appointed by a group of shareholders that consists of the company’s founders representing about 13 percent of shares and votes; and
  • Anders Vedin, chairman of the board of IRLAB Therapeutics AB.

The nomination committee’s proposal will be presented in the summon to the annual general meeting 2020 and on the company’s web page – irlab.se.

Shareholders who wish to submit proposals to the nomination committee may contact the nomination committee at the company’s postal address or e-mail –  info@irlab.se. In order to enable the nomination committee to take proposals into consideration they must be submitted in reasonable time prior to the annual general meeting and no later than January 31, 2020.